The supply is beginning to stabilize, but certain doses may still be limited or sell out quicklyespecially in high-demand areas
For example, in this study, liraglutide helped people lose almost 13 pounds more than a placebo over 1 year, and over 2 years, it reduced the prevalence of prediabetes by 52% and metabolic syndrome by 59%
As of 2024, most commercially available "GLP-1 patches" do not actually contain pharmaceutical-grade GLP-1 receptor agonists
As demand increases for GLP-1 medications, replicating the rigorous weight monitoring protocols used in clinical trials can be challenging
Ive seen it firsthand: patients lose a significant amount of weight, then stop the medication about a year in
Unlike low-touch programs, patients receive: Consistent communication with a licensed provider Flexible telehealth appointments Support for microdosing when appropriate Personalized treatment plans that evolve with progress Learn more about available programs here: GLP-1 Weight Loss Plans Why Provider-Led GLP-1 Care Matters GLP-1 medications like Semaglutide and Tirzepatide are powerful tools but results depend heavily on proper guidance
